Intercept Pharmaceuticals's EVP & Chief Commercial Officer just disposed of 171 shares

Linda M Richardson, Intercept Pharmaceuticals's EVP & Chief Commercial Officer, recently disposed of 171 shares of the company. The disposals took place at $14.92 per share, on August 15, 2021. Richardson still owns 26,524 shares of the company. Richardson operates out of New York, NY. Some additional info was provided as follows:

Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Intercept Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

Intercept Pharmaceuticals Reports Second Quarter 2022 Financial Results And Provides Business Update - Aug. 3, 2022
Intercept Pharmaceuticals Just Filed Its Quarterly Report: 14.   Net Loss Per ... - Aug. 3, 2022
Intercept Pharmaceuticals's General Counsel just disposed of 771 shares - Aug. 3, 2022
On July - July 26, 2022
Intercept Pharmaceuticals's Chief Qual. Officer & SVP Ops. just disposed of 436 shares - July 13, 2022

Auto Refresh